News
Harvard's latest research has explored how your career choice may impact your memory function. Using death certificates from ...
18h
MedPage Today on MSNCycling in Midlife Tied to Lower Risk of DementiaUsing physically active transportation modes in midlife -- particularly cycling -- was tied to lower dementia risk and ...
5d
News-Medical.Net on MSNAlzheimer's gene therapy could help protect the brain from damage and preserve cognitive functionResearchers at University of California San Diego School of Medicine have developed a gene therapy for Alzheimer's disease ...
A novel gene therapy for Alzheimer's disease, which showed promise to protect the brain from damage and preserve cognitive ...
Researchers at the University of California San Diego School of Medicine have developed a gene therapy for Alzheimer's ...
Brazilian researchers found that boosting the synthesis of hevin, a glycoprotein naturally secreted by astrocytes, led to ...
There are more than 50 million people worldwide with dementia as of 2020. In 2024, it was estimated that there was almost ...
13d
News Medical on MSNKey Protein in Astrocytes Drives Alzheimer’s Disease NeurodegenerationResearchers at the University of Barcelona discovered the RTP801 protein's key involvement in Alzheimer’s cognitive decline, ...
Alzheimer's affects 57 million globally, causing cognitive decline due to abnormal brain proteins. The new therapy targets brain cell behavior, aiming to address the disease's root cause.
Lemborexant, a medication commonly used to treat insomnia, may help protect the brain from tau buildup, a marker of Alzheimer ...
UCLA researchers have developed a drug that counteracts the impaired cognition caused by Alzheimer’s disease and ...
By reprogramming brain cells, a new gene therapy approach for Alzheimer's developed by UC San Diego researchers could address ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results